1213 GMT - Bayer anticipates a tough agriculture market in 2026, but expects benefits from a restructuring of its agricultural business to result in improvements in the unit's top and bottom lines, division head Rodrigo Santos says. "We expect ag market fundamentals to remain challenging and project below-average market growth," Santos says in a call with reporters. Bayer guided for sales at its agricultural business to be flat or rise by up to 3% excluding currency changes in 2026. The division's Ebitda before special items margin is expected to rise to between 20% and 22% at constant currency, from 19% in 2025. Santos attributes the expected improvement to cost discipline, as well as to pricing and sales mix benefits from its portfolio streamlining. Bayer shares fall 3.4%. (adria.calatayud@wsj.com)
(END) Dow Jones Newswires
March 04, 2026 07:13 ET (12:13 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments